Altered glycaemia differentially modulates efflux transporter expression and activity in hCMEC/D3 cell line

Neuroscience Letters

Volumn 598, Issue , 2015, Pages 59-65

  Sajja, Ravi K ^a   Cucullo, Luca ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Alternative; BBB; Diabetes; Drug resistance; Glycemic variability; Hypoglycemia; Transcriptome; Transporter

Indexed keywords

1,2,3,4,6,7,12,12A OCTAHYDRO 6 ISOBUTYL 9 METHOXY 1,4 DIOXOPYRAZINO[1',2':1,6]PYRIDO[3,4 B]INDOLE 3 PROPANOIC ACID TERT BUTYL ESTER; ABC TRANSPORTER; BREAST CANCER RESISTANCE PROTEIN; HYDROCORTISONE; LUCIFERIN; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 7; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 4; ABCC4 PROTEIN, HUMAN; ABCG2 PROTEIN, HUMAN; GLUCOSE; MESSENGER RNA; MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1; TUMOR PROTEIN;

APICAL MEMBRANE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CAPILLARY ENDOTHELIAL CELL; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; HYPERGLYCEMIA; HYPOGLYCEMIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; WESTERN BLOTTING; CELL LINE; CYTOLOGY; GENETICS; METABOLISM; MICROVASCULATURE; VASCULAR ENDOTHELIUM;

ATP-BINDING CASSETTE TRANSPORTERS; BLOOD-BRAIN BARRIER; CELL LINE; ENDOTHELIUM, VASCULAR; GLUCOSE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; MICROVESSELS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; P-GLYCOPROTEIN; RNA, MESSENGER;

EID: 84930225232     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2015.05.015     Document Type: Article

References (28)

1. Palmiotti C.A., Prasad S., Naik P., Abul K.M., Sajja R.K., Achyuta A.H., Cucullo L. In vitro cerebrovascular modeling in the 21st century: current and prospective technologies. Pharm. Res. 2014, 31:3229-3250.
2. Loscher W., Potschka H. Drug resistance in brain diseases and the role of drug efflux transporters. Nat. Rev. Neurosci. 2005, 6:591-602.
3. Miller D.S., Cannon R.E. Signaling pathways that regulate basal ABC transporter activity at the blood- brain barrier. Curr. Pharm. Des. 2014, 20:1463-1471.
4. Bauer B., Hartz A.M., Miller D.S. Tumor necrosis factor alpha and endothelin-1 increase P-glycoprotein expression and transport activity at the blood-brain barrier. Mol. Pharmacol. 2007, 71:667-675.
5. Goralski K.B., Hartmann G., Piquette-Miller M., Renton K.W. Downregulation of mdr1a expression in the brain and liver during CNS inflammation alters the in vivo disposition of digoxin. Br. J. Pharmacol. 2003, 139:35-48.
6. Prasad S., Sajja R.K., Naik P., Cucullo L. Diabetes mellitus and blood-brain barrier dysfunction: an overview. J. Pharmacovigil. 2014, 2:125.
7. Sajja R.K., Prasad S., Cucullo L. Impact of altered glycaemia on blood-brain barrier endothelium: an in vitro study using the hCMEC/D3 cell line. Fluids Barriers CNS 2014, 11:8.
8. Liu H., Zhang D., Xu X., Liu X., Wang G., Xie L., Pang X., Liu L. Attenuated function and expression of P-glycoprotein at blood-brain barrier and increased brain distribution of phenobarbital in streptozotocin-induced diabetic mice. Eur. J. Pharmacol. 2007, 561:226-232.
9. Maeng H.J., Kim M.H., Jin H.E., Shin S.M., Tsuruo T., Kim S.G., Kim D.D., Shim C.K., Chung S.J. Functional induction of P-glycoprotein in the blood-brain barrier of streptozotocin-induced diabetic rats: evidence for the involvement of nuclear factor-kappaB a nitrosative stress-sensitive transcription factor, in the regulation. Drug Metab. Dispos. 2007, 35:1996-2005.
10. Poller B., Gutmann H., Krahenbuhl S., Weksler B., Romero I., Couraud P.O., Tuffin G., Drewe J., Huwyler J. The human brain endothelial cell line hCMEC/D3 as a human blood-brain barrier model for drug transport studies. J. Neurochem. 2008, 107:1358-1368.
11. Weksler B.B., Subileau E.A., Perriere N., Charneau P., Holloway K., Leveque M., Tricoire-Leignel H., Nicotra A., Bourdoulous S., Turowski P., Male D.K., Roux F., Greenwood J., Romero I.A., Couraud P.O. Blood-brain barrier-specific properties of a human adult brain endothelial cell line. FASEB J. 2005, 19:1872-1874.
12. Russo V.C., Higgins S., Werther G.A., Cameron F.J. Effects of fluctuating glucose levels on neuronal cells in vitro. Neurochem. Res. 2012, 37:1768-1782.
13. Li W., Liu X., Yanoff M., Cohen S., Ye X. Cultured retinal capillary pericytes die by apoptosis after an abrupt fluctuation from high to low glucose levels: a comparative study with retinal capillary endothelial cells. Diabetologia 1996, 39:537-547.
14. Dauchy S., Miller F., Couraud P.O., Weaver R.J., Weksler B., Romero I.A., Scherrmann J.M., De W., Decleves I.X. Expression and transcriptional regulation of ABC transporters and cytochromes P450 in hCMEC/D3 human cerebral microvascular endothelial cells. Biochem. Pharmacol. 2009, 77:897-908.
15. Sajja R.K., Green K.N., Cucullo L. Altered nrf2 signaling mediates hypoglycemia-induced blood-brain barrier endothelial dysfunction in vitro. PLoS One 2015, 10:e0122358.
16. Tai L.M., Reddy P.S., Lopez-Ramirez M.A., Davies H.A., Male D.K., Loughlin A.J., Romero I.A. Polarized P-glycoprotein expression by the immortalised human brain endothelial cell line, hCMEC/D3, restricts apical-to-basolateral permeability to rhodamine 123. Brain Res. 2009, 14-24.
17. Bakhsheshian J., Wei B.R., Chang K.E., Shukla S., Ambudkar S.V., Simpson R.M., Gottesman M.M., Hall M.D. Bioluminescent imaging of drug efflux at the blood-brain barrier mediated by the transporter ABCG2. Proc. Natl. Acad. Sci. U. S. A 2013, 110:20801-20806.
18. Maines L.W., Antonetti D.A., Wolpert E.B., Smith C.D. Evaluation of the role of P-glycoprotein in the uptake of paroxetine clozapine, phenytoin and carbamazapine by bovine retinal endothelial cells. Neuropharmacology 2005, 49:610-617.
19. Nowicki M.T., Aleksunes L.M., Sawant S.P., Dnyanmote A.V., Mehendale H.M., Manautou J.E. Renal and hepatic transporter expression in type 2 diabetic rats. Drug Metab. Lett. 2008, 2:11-17.
20. Kamei J., Hirano S., Miyata S., Saitoh A., Onodera K. Effects of first- and second-generation histamine-H1-receptor antagonists on the pentobarbital-induced loss of the righting reflex in streptozotocin-induced diabetic mice. J. Pharmacol. Sci. 2005, 97:266-272.
21. Liu Y.C., Liu H.Y., Yang H.W., Wen T., Shang Y., Liu X.D., Xie L., Wang G.J. Impaired expression and function of breast cancer resistance protein (Bcrp) in brain cortex of streptozocin-induced diabetic rats. Biochem. Pharmacol. 2007, 74:1766-1772.
22. Reichel V., Burghard S., John I., Huber O. P-glycoprotein and breast cancer resistance protein expression and function at the blood-brain barrier and blood-cerebrospinal fluid barrier (choroid plexus) in streptozotocin-induced diabetes in rats. Brain Res. 2011, 1370:238-245.
23. Warren M.S., Zerangue N., Woodford K., Roberts L.M., Tate E.H., Feng B., Li C., Feuerstein T.J., Gibbs J., Smith B., de Morais S.M., Dower W.J., Koller K.J. Comparative gene expression profiles of ABC transporters in brain microvessel endothelial cells and brain in five species including human. Pharmacol. Res. 2009, 404-413.
24. Ohtsuki S., Ikeda C., Uchida Y., Sakamoto Y., Miller F., Glacial F., Decleves X., Scherrmann J.M., Couraud P.O., Kubo Y., Tachikawa M., Terasaki T. Quantitative targeted absolute proteomic analysis of transporters, receptors and junction proteins for validation of human cerebral microvascular endothelial cell line hCMEC/D3 as a human blood-brain barrier model. Mol. Pharm. 2013, 10:289-296.
25. Monnier L., Colette C., Owens D.R. Glycemic variability: the third component of the dysglycemia in diabetes. Is it important? How to measure it?. J. Diabetes Sci. Technol. 2008, 2:1094-1100.
26. Tornio A., Niemi M., Neuvonen P.J., Backman J.T. Drug interactions with oral antidiabetic agents: pharmacokinetic mechanisms and clinical implications. Trends Pharmacol. Sci. 2012, 33:312-322.
27. Liu H., Liu L., Li J., Mei D., Duan R., Hu N., Guo H., Zhong Z., Liu X. Combined contributions of impaired hepatic CYP2C11 and intestinal breast cancer resistance protein activities and expression to increased oral glibenclamide exposure in rats with streptozotocin-induced diabetes mellitus. Drug Metab. Dispos. 2012, 40:1104-1112.
28. Liu L., Liu X.D. Alterations in function and expression of ABC transporters at blood-brain barrier under diabetes and the clinical significances. Front. Pharmacol. 2014, 5:273.